Page last updated: 2024-09-03

5-(tetradecyloxy)-2-furancarboxylic acid and Kahler Disease

5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Medina, EA; Oberheu, K; Ortega, V; Oyajobi, BO; Polusani, SR; Velagaleti, GV1

Other Studies

1 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and Kahler Disease

ArticleYear
PKA/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells.
    Leukemia, 2014, Volume: 28, Issue:10

    Topics: Acetyl-CoA Carboxylase; Adipokines; Adiponectin; AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Disease Progression; Fatty Acids; Furans; Humans; Lipogenesis; Metabolism, Inborn Errors; Mice; Multiple Myeloma; Obesity; Signal Transduction

2014